logo
People Power: The Importance Of Human Capital

People Power: The Importance Of Human Capital

Forbes17-07-2025
If you hire amazing people who enthusiastically support your mission, they can help share the burden of running a growing company.
I want to share a truth you might find surprising: as a business owner—and especially if you are an entrepreneur starting a new business—your biggest challenge, your greatest risk, your most important task, isn't raising capital or implementing processes. It's making sure the people you surround yourself with will be the ones who will truly elevate your organization's capabilities. Sure, raising capital is important, but your 'human capital' is even critical.
The phrase may sound cold, devoid of emotion, but as I like to say, 'Feelings aren't what lands on a spreadsheet.' Human capital can be defined as the economic value of your employees to your business. Your greatest expense is your employees, but they are also your greatest asset.
The fact is, if you hire amazing people who enthusiastically support your mission, they can help share the burden of running a growing company with all of the varied challenges that it poses and help you create a competitive advantage in your market. But hiring even one bad apple can keep you awake at night and question your sanity. I know this firsthand!
This is true of all companies, regardless of size, but it is especially true for small businesses. In running a small business, there are ripple effects with every interaction that feel far greater, which is why I have found that most business owners hang on to people who are wrong for the job longer than they should. As an entrepreneur, your company is an extension of you, almost like a parent-child relationship. In those situations, there are consequences and dependencies that have a greater impact on a team of ten than a team of one hundred or one thousand.
That is why getting hiring right is the single most important thing you can do for your company. To be successful in business, you need to look at all aspects of your company with a business lens. Sure, calling your employees 'human capital' may feel like you are diminishing them individually. But at the same time, you cannot afford to pour hours of your time coaching one underperforming employee who has a crappy attitude, even though said crappy person would appreciate the added attention.
Regardless of the size and stage of a company, getting hiring right is critical. The better the teams, the better prepared you are to deal with competition and market challenges. At the same time, people present their own challenges; what I hear from nearly all the clients I've advised and the entrepreneurs I've coached is 'businessing' is the easy part, and 'peopleing' is what makes that hard.
People are wonderful and complicated. Universally, regardless of the industry you are in, the people you hire will always add dynamic complexities. You can have all the practical and operational tools and tactics in place. You can write the most sound business strategy and be well capitalized. You can monitor, check, adjust, optimize, and execute in real time all day long. Your people, though, are your wild card. People can be pure pandemonium.
That's why you need to hire people who are custom-fit for you and your company. The sooner you can establish sound hiring practices, the greater your chance of success. Even when you have those in place, you still need to remember that no matter how much you do, people are wonderful and maddening, and oh so unpredictable—and you won't get far without them.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Molson Coors Cuts Outlook as Beer Demand Slumps, Costs Rise
Molson Coors Cuts Outlook as Beer Demand Slumps, Costs Rise

Wall Street Journal

time15 minutes ago

  • Wall Street Journal

Molson Coors Cuts Outlook as Beer Demand Slumps, Costs Rise

Molson Coors TAP 0.91%increase; green up pointing triangle lowered its full-year sales and profit forecasts, citing weaker beer demand, rising aluminum costs and slower-than-expected market share gains. The outlooks were overshadowed by a slight rise in profit and higher-than-expected sales in the second quarter, which edged shares higher in morning trading Tuesday. The stock was recently up 0.7%, to $48.94, and is down 4.3% over the past year.

This Popular Bond ETF Might Be Marriage Material. Here's the Best Way to Say ‘I Do.'
This Popular Bond ETF Might Be Marriage Material. Here's the Best Way to Say ‘I Do.'

Yahoo

time42 minutes ago

  • Yahoo

This Popular Bond ETF Might Be Marriage Material. Here's the Best Way to Say ‘I Do.'

What do you get when you take the option collar, the options strategy I write about regularly for Barchart, and remove the covered call, arguably the least important yet most popular piece? The answer is a 'married put strategy.' And in this article, I'm going to explain why this is a good time to leave the covered call at home. In the current market environment, the exchange-traded fund (ETF) I'm focusing on might be better off without the covered call. Why? Sinking option volatility. That makes options cheaper. But since the put side of a collar is bought, cheap is good. More News from Barchart Options Traders Expected Palantir Stock's Tamest Earnings Reaction in a Year. Did They Get It Right? PayPal Maintains its Huge FCF Guidance Despite a Q2 Drop - Is PYPL Stock Too Cheap? Option Volatility And Earnings Report For Aug 4 - 8 Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Invest in Gold American Hartford Gold: #1 Precious Metals Dealer in the Nation Thor Metals Group: Best Overall Gold IRA Priority Gold: Up to $15k in Free Silver + Zero Account Fees on Qualifying Purchase However, the call side of the options collar involves selling a covered call option. The usual motivation for that extra step is to pay for the put option that guards a stock or ETF from diving too far down. That covered call option is also somewhat inexpensive these days. And when we're talking about selling away some of our potential upside profits, in exchange for some cash flow now to reduce the cost of the puts, it doesn't make as much sense. Because the amount received for the call-writing transaction is not very much, relative to recent history. TLT: The Case for a Married Put Strategy A case in point for why a married put strategy might make more sense now than an option collar strategy is the iShares 20+ Year Treasury Bond ETF (TLT), which as shown below has an IV Rank of 15%. That means over the past 12 months, the volatility level of TLT has been higher than the current 14% level 85% of the time. This means we don't have to worry too much about volatility here. As a side note, fans of covered call ETFs should pay close attention. Given lower volatility levels, the risk management provided by covered call ETFs today is much less powerful than it has been throughout the rest of 2025. As with collars, there are many ways to approach the combination of marrying TLT shares and a TLT put option for every 100 shares owned. But the takeaway from this one example below is that I can go out to Nov. 21, and assuming I bought TLT around $88 a share, I can also buy a put struck at $88. This means that except for the cost to buy the puts, I can't end up with less than $88 a share of value… no matter what happens with interest rates or how much TLT falls. Plus, the cost to buy the puts is only $2.61 here, so about 3% of that $88 strike price. Bottom line: 3% is my worst-case loss. TLT's Upside Is Capped At…. It's Not! My upside? Unlimited through Nov. 21, with that protection in place. We have recently experienced a period in which the long end of the yield curve has been quiet and not very volatile. It is as if it is trying to make up its mind what to do. If the recent saber-rattling in Washington tips in the direction of lower rates, TLT could be a big winner. However, in an uncertain, politically charged situation like this, having relatively cheap put protection can be a valuable hedge. And as long as the covered call part of a collar is not especially attractive, this could be an opportunity to pursue unfettered upside. That's one key advantage of the married put strategy versus the collar. But if you profit from this trade… Please, no gifts for the happy couple. On the date of publication, Rob Isbitts did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Pharmaceutical Excipients Market Size Forecasted to Surpass USD 15.43 Billion by 2034 Amid Rising Demand for Novel Drug Delivery Systems
Pharmaceutical Excipients Market Size Forecasted to Surpass USD 15.43 Billion by 2034 Amid Rising Demand for Novel Drug Delivery Systems

Yahoo

time42 minutes ago

  • Yahoo

Pharmaceutical Excipients Market Size Forecasted to Surpass USD 15.43 Billion by 2034 Amid Rising Demand for Novel Drug Delivery Systems

The global pharmaceutical excipients market size is on track to exceed USD 15.43 billion by 2034, rising from USD 9.31 billion in 2025 at a CAGR of 5.75%, according to a new report by Precedence Research. Ottawa, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The worldwide pharmaceutical excipients market size was valued at USD 8.82 billion in 2024, and it is expected to attain USD 15.43 billion by 2034. The growing pharmaceutical industry and increasing demand for biologic and generic drugs drive the market growth. The market is undergoing a significant transformation, driven by the rise of biologics, demand for personalized medicine, and innovations in drug delivery systems. With the market expected to grow at a CAGR of 5.75% from 2025 to 2034, companies across the value chain are eyeing excipients as a critical component for competitive advantage. Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for Before You Buy – Get the Sample Report@ Pharmaceutical Excipients Market Key Takeaways The pharmaceutical excipients market size reached USD 8.82 billion in 2024. It is expected to exceed USD 15.43 billion by 2034. The market is growing at a CAGR of 5.75% between 2025 and 2034. The North American market size was calculated at USD 3.15 billion in 2024. North America accounted for the largest market share of 38.32% in 2024. By excipient type, the lactose-based excipients contributed the biggest market share of 41.26% in 2024. By functionality, the fillers and diluents segment generated the major market share in 2024. By functionality, the coating agents segment is expected to grow at a significant CAGR from 2025 to 2034. By excipient type, the lactose-based segment captured the highest market share 2024. By excipient type, the cellulose-based segment is projected to grow at a notable CAGR from 2025 to 2034. Pharmaceutical Excipients Market Overview What are Pharmaceutical Excipients? Pharmaceutical excipients are inactive substances formulated for drug production. They are used alongside active pharmaceutical ingredients. Pharmaceutical excipients prevent degradation and enhance the absorption of the drug. They are widely used in the production of capsules, tablets, and other drugs. They enhance the appearance, taste, texture, and compressibility of medications. Pharmaceutical excipients offer bulk to medication formulations and improve safety, efficacy, & stability of drugs. They are widely used in formulations of tablets, liquid dosage forms, capsules, creams, and ointments. 'As pharmaceutical companies strive for innovation in formulations and cost-effective manufacturing, multifunctional excipients are emerging as game-changers,' said Deepa Pandey, Principal Consultant at Precedence Research. Top Pharmaceutical Excipients Name Role Examples Diluents Provides Bulk to Formulation Microcrystalline Cellulose Calcium Phosphate Lactose Starch Binders Hold Powdered Ingredients Together Hydroxypropyl Cellulose Polyethylene Glycol Povidone Microcrystalline Cellulose Gelatin Disintegrants Break Up Tablets into Smaller Parts in Liquid Form Starch Croscarmellose Sodium Sodium Starch Glycolate Lubricants Avoid Sticking of Ingredients to Equipment Stearic Acid Magnesium Stearate Glidants Enhance Powder Mixture Flow Talc Colloidal Silicon Dioxide ➤ Get the Full Report @ Pharmaceutical Excipients Market Opportunity What is the Opportunity for the Pharmaceutical Excipients Market? The Growing Demand for Multifunctional Excipients The increasing demand for multifunctional excipients in the pharmaceutical industry for the production of pharmaceutical products creates an opportunity for the market. The growing focus on enhancing drug performance and simplifying drug formulation processes increases demand for multifunctional excipients. The increasing focus on reducing manufacturing costs and improving compliance fuels demand for multifunctional excipients. The focus on the development of sustained-release formulations and fast-dissolving tablets increases the need for multifunctional excipients. The increasing focus on personalised medicines and rapid growth in the biopharmaceutical industry increases demand for multifunctional excipients. The expansion of the healthcare industry and the growing demand for various medications are fueling demand for multifunctional excipients. The growing demand for stabilizing, binding, and disintegrating in one form fuels demand for multifunctional excipients. The growing demand for multifunctional excipients unlocks an opportunity for the growth of the pharmaceutical excipients market. For instance, the development of orally disintegrating tablets has driven demand for excipients that combine binding, taste-masking, and rapid disintegration in a single material. Limitations and Challenges in the Pharmaceutical Excipients Market Why is Pharmaceutical Excipients Development Cost High? Despite several applications of pharmaceutical excipients, the high development cost restricts the market growth. Factors like complex manufacturing processes, stringent regulatory environments, production scaling up, and extensive testing increase the development cost. The need for extensive research & development for the development of drugs increases the cost. The extensive processes like regulatory approval, research time, and testing increase the development cost. Complex manufacturing processes and the need for specialized equipment lead to higher development costs. The need for higher investment in large-scale manufacturing and lengthy development, and complex testing directly impacts the market. The regulatory approvals, like extensive evaluations and approval from regulatory bodies, increase the cost. The high development cost hampers the growth of the pharmaceutical excipients market. The timing has never been more critical. With global emphasis on rapid drug development, personalized medicine, and biologic therapies, pharmaceutical excipients are no longer passive ingredients but active enablers of innovation, efficacy, and compliance. Scope of Pharmaceutical Excipients Market Report Attributes Statistics Market Size in 2024 USD 8.82 Billion Market Size in 2025 USD 9.31 Billion Market Size by 2034 USD 15.43 Billion CAGR 2025 to 2034 5.75% Leading Region in 2024 North America (accounted for 38.32% of market share) Fastest Growing Region Europe Base Year 2024 Forecast Period 2025 to 2034 Segments Covered Functionality, Excipient Type, and Regions Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa ➡️ Become a valued research partner with us ☎ Case Study: Multifunctional Excipients Streamline Tablet Production for Generic Drug Manufacturer In 2024, a leading Indian generic pharmaceutical company adopted a multifunctional excipient combining binding, disintegration, and flow-enhancing properties in a reformulated version of its high-volume antihypertensive tablet. Key Outcomes: Reduced formulation steps by 30%, minimizing the use of multiple individual excipients. Cut production costs by 18% through improved compression and faster manufacturing cycles. Achieved 25% faster dissolution rate, improving patient compliance and therapeutic onset. Streamlined regulatory submission, thanks to excipient's prior GRAS (Generally Recognized As Safe) status and established supplier documentation. This case demonstrates the cost and performance benefits driving global demand for multifunctional excipients, particularly among high-volume, cost-sensitive drug manufacturers. Gain a competitive edge in formulation and drug delivery our pharma research team at sales@ or book a 1:1 session to unlock segment-specific insights. Pharmaceutical Excipients Market Key Regional Insights How Did North America Dominate Pharmaceutical Excipients Market in 2024? North America dominated the pharmaceutical excipients market in 2024, owing to the strong presence of a well-developed and advanced pharmaceutical industry in the region increases the demand for pharmaceutical excipients for the production of drugs. The extensive investment in research & development of pharmaceuticals helps in the market growth. The growing demand for generic drugs increases demand for pharmaceutical excipients. The increasing development of advanced drug formulations and drug delivery systems increases demand for pharmaceutical excipients. The stringent regulations for the development of excipients help the market growth. The increasing demand for personalised medicines and focus on biologics drive the market growth. U.S. Pharmaceutical Excipients Market Size and Forecast 2025 to 2034 How big is the U.S. Pharmaceutical Excipients Market? According to Precedence Research, the U.S. pharmaceutical excipients market size reached USD 2.90 billion in 2024 and is expected to grow from USD 3.08 billion in 2025 to USD 5.32 billion by 2034, registering a CAGR of 6.26% from 2025 to 2034. Key Market Drivers and Insights Strong generics penetration in the U.S. elevates demand for excipients, especially in oral dosage forms like tablets and capsules. Advanced formulations, including controlled-release and biopharma delivery systems, are boosting growth in high-performance excipients and coating agents. Regulatory clarity and infrastructure investment maintain the region's dominance, with substantial R&D in U.S.-based excipient solutions. The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report@ How is Asia Pacific the Fastest Growing in the Pharmaceutical Excipients Market? Asia Pacific is experiencing the fastest growth in the market during the forecast period, owing to the growing healthcare spending and rising demand for various pharmaceutical products that increase the demand for pharmaceutical excipients. The increasing expansion of generic drugs helps the market growth. The focus on personalised medicines and advancement in drug delivery systems fuels demand for pharmaceutical excipients. The strong government support for the pharmaceutical industry and growing investment in R&D help the market growth. The rise in biosimilars & biologics and the expansion of nutraceuticals support the market growth. Top Three Asian Exporters of Pharmaceutical Excipients: Countries Export Leading Suppliers Japan 356 Shipments SHIN ETSU CHEMICAL CO, LTD China 200 Shipments WELLSTARS INTERNATIONAL CO, LTD India 106 Shipments Amtec Health Care Pvt Ltd (Source: Pharmaceutical Excipients Market Segmentation Analysis: Functionality Analysis Why did Fillers and Diluents Segment Dominate the Pharmaceutical Excipients Market? The fillers and diluents segment dominated the pharmaceutical excipients market in 2024. The easy availability of different forms and grades of fillers and diluents helps the market growth. The need for achieving the desired weight & size of capsules & tablets increases demand for fillers & diluents. They contribute to tablet content uniformity and improve the flow properties of tablet formulations. Fillers & diluents enhance production efficiency, tablet compression, and flow properties. The growing demand for different starches, lactose, and microcrystalline fillers & diluents drives the market growth. The coating agent segment is significantly growing in the market during the forecast period. The growing focus on improving patient experience increases demand for coatings to cover up the unpleasant odor and taste of medications. The increasing demand for protecting active ingredients in pharmaceutical production fuels demand for coating agents. The growing prevalence of chronic diseases increases demand for coated medications. Coating agents enhance drug delivery and control drug release in the body. The rising adoption of oral solid medications like capsules & tablets supports the market growth. Excipient Type Analysis How Lactose-Based Segment Held the Largest Share of the Pharmaceutical Excipients Market? The lactose-based segment held the largest revenue share of the pharmaceutical excipients market in 2024 due to growing demand for binder, flow agent, filler, and diluent in various pharmaceutical applications that increases demand for lactose-based excipients. They are available in various forms like spray-dried, anhydrous, & monohydrate and are compatible with various APIs. Lactose-based excipients have good flowability, low hygroscopicity, excellent compressibility, and good solubility. They are easily available and cost-effective for pharmaceutical production. The increasing demand across applications like lyophilization, solid dosage forms, and inhalation products drives the market growth. The cellulose-based segment is significantly growing in the market during the forecast period. The growing demand for cellulose-based excipients across various pharmaceutical applications like controlled-release formulations, tablet binding, and disintegration helps the market growth. The increasing demand for generic drugs fuels demand for cellulose-based excipients. They are derived from a plant source and improve the bioavailability of less soluble drugs. The growing development of patient-friendly drug delivery systems and orally dissolving tablets supports the market growth. ✚ Related Topics You May Find Useful ➤ ➡️Pharmaceutical Manufacturing Market: Advancing efficiency through automation, AI, and global capacity expansion ➡️Pharmaceutical Chemicals Market: Meeting rising API demand with stringent quality and compliance standards ➡️Nutraceutical Excipients Market: Enhancing bioavailability and stability with clean-label formulations ➡️High-Potency API Market: Enabling targeted therapies for oncology and rare diseases ➡️Biotech Ingredients Market: Supporting biologics growth with innovative, high-purity ingredients ➡️Pharmaceutical Intermediates Market: Accelerating complex drug development via outsourcing and specialty production ➡️Pharma Contract Manufacturing & Research Market: Strengthening drug pipelines with advanced outsourcing solutions Pharmaceutical Excipients Market Top Companies The pharmaceutical excipients market is dominated by key players who collectively command the largest market share and significantly influence industry trends. Ashland Global Holdings BASF SE DuPont Roquette Feres Evonik Industries AG Associated British Foods Archer Daniels Midland Company Lubrizol Corporation Croda International Kerry Group Recent Developments In November 2024, Clariant launched new high-performing excipients for effective medicines. The excipients are available for various applications like parenteral formulations and sensitive active pharmaceutical industries. The range offers high-quality, tailored, reliable, and cost-effective solutions for the healthcare sector in India. (Source: In January 2025, GELITA launched Endotoxin Controlled Excipients for pharmaceutical and bioscience applications. The product range includes MEDELLAPRO and VACCIPRO, that used in applications like 3D bioprinting, vaccine stabilisation, and medical devices. The excipients ensure patient safety and well-being. (Source: In December 2023, Roquette launched three new excipient grades, MICROCEL 113 SD, LYCATAB CT-LM, and MICROCEL 103 SD. The new excipients support the development of drugs and focus on improving the experience of producers & patients. (Source: In May 2025, Pharcos Specialty Ltd launched India's first homegrown hydroxypropyl methylcellulose excipients for the pharmaceutical industry. The excipients are used in the coating of tablets & pellets, stabilization of suspensions, thickening agent in pharmaceutical formulations, controlled-release matrix system, wet granulation & binder system, manufacturing vegetarian tablets, and frozen food & food dietary. (Source: Pharmaceutical Excipients Market Segments Covered in the Report By Functionality Fillers and Diluents Suspending and Viscosity Agents Coating Agents Binders Disintegrants Colorants Lubricants and Glidants Preservatives Emulsifying Agents Flavoring Agents and Sweeteners Other Functionalities By Excipient Type Lactose-based Excipients α-lactose monohydrate Anhydrous α-lactose Anhydrous β-lactose Amorphous Lactose Cellulose-based Microcrystalline Cellulose (MCC) Cellulose Ethers Others Starches Carboxymethylcellulose Sodium (CCS) Sodium Starch Glycolate (SSG) Fine Chemicals Mannitol Biopharma Excipients Others By Region North America U.S. Canada Europe Germany UK France Italy Spain Sweden Denmark Norway Asia Pacific China Japan India South Korea Thailand Latin America Brazil Mexico Argentina Middle East & Africa South Africa UAE Saudi Arabia Kuwait Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as Immediate Delivery Available | Buy This Premium Research Report@ You can place an order or ask any questions, please feel free to contact at sales@ | +1 804 441 9344 Stay Ahead with Precedence Research Subscriptions Unlock exclusive access to powerful market intelligence, real-time data, and forward-looking insights, tailored to your business. From trend tracking to competitive analysis, our subscription plans keep you informed, agile, and ahead of the curve. Browse Our Subscription Plans@ About Us Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally. Web: Our Trusted Data Partners: Towards Healthcare | Towards Packaging | Towards Automotive | Towards Chem and Materials | Towards FnB | Towards Consumer Goods | Statifacts | Towards EV Solutions | Towards Dental | Nova One Advisor | Market Stats Insight Get Recent News: For the Latest Update Follow Us: LinkedIn | Facebook | TwitterError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store